Bliss GVS Pharma Limited has initiated a postal ballot to seek shareholder approval for two new Employee Stock Option Plans (ESOPs). The plans involve the issuance of up to 7.35 million options combined, targeting senior executives and general employees. Shareholders can cast their votes via remote e-voting starting October 29 through November 27, 2026. This move formalizes the company's incentive structure, though investors should monitor the potential equity dilution of approximately 6.91% if all options are fully exercised.
Bliss GVS Pharma Seeks Shareholder Approval for New ESOP Schemes
Up to 7.35 million options proposed, representing a 6.91% cumulative equity dilution impact.
Reader Takeaway: The new ESOPs incentivize performance and retention, but investors should monitor the cumulative 6.91% potential equity dilution.
What just happened
Bliss GVS Pharma Limited has issued a Notice of Postal Ballot to obtain shareholder consent for two distinct Employee Stock Option Plans (ESOPs) via remote e-voting. The voting window opens on October 29, 2026, at 9:00 a.m. IST and closes on November 27, 2026, at 5:00 p.m. IST. Results are expected by November 30, 2026.
Key Proposed Plans
- Senior Executive ESOP 2026: Offers 2.65 million options for the CEO, Mr. Rahul Adakmol, representing 2.49% dilution. The exercise price is fixed at INR 10.
- Employee ESOP 2026: Offers 4.7 million options for present and future employees, representing 4.42% dilution. The exercise price is also INR 10.
Why this matters
These plans aim to align employee interests with long-term company growth. Vesting for the broader employee plan is tied to performance metrics, including Consolidated Revenue, Consolidated Profit After Tax (PAT), and R&D spending benchmarks. The company will manage these plans directly without a trust.
Risks to watch
Shareholders should consider the dilution effect on their existing holdings. With a total of 7.35 million options proposed, full exercise would increase the company's issued and paid-up capital. The ultimate impact depends on the company's ability to achieve the performance-linked vesting requirements.
What to track next
The voting process will be overseen by scrutinizer Mr. Vijay Yadav of M/s. AVS & Associates. Investors should watch for the announcement of the e-voting results on or before November 30, 2026.